ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 147 filers reported holding ASCENDIS PHARMA A/S in Q4 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $644,000 | -22.8% | 5,000 | 0.0% | 0.17% | -38.7% |
| Q4 2020 | $834,000 | +8.0% | 5,000 | 0.0% | 0.27% | +56.6% |
| Q3 2020 | $772,000 | +4.3% | 5,000 | 0.0% | 0.18% | +4.8% |
| Q2 2020 | $740,000 | +31.4% | 5,000 | 0.0% | 0.17% | +57.5% |
| Q1 2020 | $563,000 | -71.3% | 5,000 | -64.5% | 0.11% | -28.9% |
| Q4 2019 | $1,960,000 | +1.8% | 14,090 | -29.6% | 0.15% | +24.2% |
| Q3 2019 | $1,926,000 | – | 20,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |